Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis

We report a case of acute weight gain after switching from emtricitabine/tenofovir disoproxil to emtricitabine/tenofovir alafenamide for human immunodeficiency virus pre-exposure prophylaxis.

Detalles Bibliográficos
Autores principales: Selvaraj, Shailendra V, Bares, Sara H, Havens, Joshua P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588108/
https://www.ncbi.nlm.nih.gov/pubmed/33134420
http://dx.doi.org/10.1093/ofid/ofaa454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588108/
https://www.ncbi.nlm.nih.gov/pubmed/33134420
http://dx.doi.org/10.1093/ofid/ofaa454

Ejemplares similares